Population PK Modeling of Dapivirine Released from Vaginal Rings

Dapivirine is a non-nucleoside reverse transcriptase inhibitor with potent antiviral activity against HIV-1. The International Partnership for Microbicides (IPM) has developed a vaginal ring containing dapivirine (25 mg) for use as a microbicide to protect women against HIV infection through sexual intercourse.

Download the document